Introduction
============

Historical perspective
----------------------

In 1825, Jean-Marc Gaspard Itard, the Chief Physician at the National Institute for Deaf Mutes in Paris, provided careful clinical observations of stereotypic movements and vocalizations in the 26-year-old Marquise de Dampierre:

> \[she\] began to have convulsive contractions in her hand and arm muscles, which manifested themselves especially at the moments in which this \[woman as a\] child tried to write as she spread her hand over the characters that she traced. After this deviation, her hand movements returned to normal once more and were subject to her will until another jolt interrupted the operation of her hand once more...soon it became certain that these movements were involuntary and convulsive, as the muscles of the shoulders, the neck and the face participated in them. The malady continued to progress, spasms were propagated in the organs of the voice and of the speech, and this young woman uttered bizarre cries and words which made no sense ([@b73-ndt-4-1111]).

The socially disabling effects of the disorder were also clear to Itard:

> Among the continuous and disordered movements which lead to these morbid contractions, those imparted by the organs of voice and speech are the only ones deserving all our attention as presenting the more rare phenomenon as well as constituting the most disagreeable inconvenience, one which prevents the person from attaining all the kindnesses society offers; because the disorder that she bears is proportional to the pleasure of which it deprives her...the more others seem revolted by her uncivilized statements, the more she is tormented by the fear of uttering them ([@b23-ndt-4-1111]).

Although George Beard (1880--1881) later described an additional fifty patients with motor tics and echolalia, the disorder was eponymously named by Jean-Martin Charcot after his student Georges Gilles de la Tourette, who had written a two-part manuscript in 1885 describing nine affected patients, including the Marquise ([@b58-ndt-4-1111]).

Clinical features of Tourette's syndrome
----------------------------------------

The clinical features of Tourette's syndrome (TS) as described by those original reports remain the basis for current diagnostic criteria. More specifically, both the Tourette Syndrome Classification Study Group and the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) ([@b145-ndt-4-1111]; [@b105-ndt-4-1111]) currently require the presence of multiple motor and vocal tics (stereotyped, purposeless, and involuntary movements or sounds) daily or intermittently over the course of over one year, and with onset in childhood (prior to eighteen years of age for the DSM-IV). An additional essential diagnostic criterion is tic variability; that is, their severity, frequency, and affected anatomic location must vary over the course of the disorder ([@b145-ndt-4-1111]).

Categorization of TS into subtypes according to the patient's symptoms has been proposed ([@b128-ndt-4-1111]; [@b116-ndt-4-1111]; [@b75-ndt-4-1111]). Simple TS is characterized by the predominance of motor and vocal tics, whereas more complex subtypes feature coprolalia, copropraxia, echolalia, echopraxia, palilalia, and/or palipraxia ([@b116-ndt-4-1111]; [@b75-ndt-4-1111]). Patients with TS may also commonly exhibit other behavioral symptoms ([@b57-ndt-4-1111]), such as attention deficit-hyperactivity disorder ([@b119-ndt-4-1111]), obsessive compulsive disorder ([@b51-ndt-4-1111]; [@b36-ndt-4-1111]), self-injurious behaviors ([@b118-ndt-4-1111]; [@b85-ndt-4-1111]; [@b87-ndt-4-1111]; [@b71-ndt-4-1111]; [@b6-ndt-4-1111]; [@b1-ndt-4-1111]), and/or anxiety disorders ([@b119-ndt-4-1111]).

Treatment of TS symptoms is pursued if the symptoms adversely affect quality of life or cause medical complications ([@b133-ndt-4-1111]). Patients who exhibit mild symptoms may require only psychobehavioral therapies and the support of family, teachers, and TS support groups ([@b83-ndt-4-1111]; [@b105-ndt-4-1111]; [@b150-ndt-4-1111]). Some patients may be able to avoid the use of pharmacological therapies since TS is unique as a hyperkinetic movement disorder in that patients describe the ability to suppress their tics ([@b39-ndt-4-1111]), at least in part. Moreover, although patients typically demonstrate a chronic disease course, symptom remission may occur spontaneously in up to 40% of patients by late adolescence and an additional 30% of patients may experience later symptom improvement ([@b27-ndt-4-1111]; [@b89-ndt-4-1111]; [@b10-ndt-4-1111]). Pharmacological therapies may be beneficial for patients whose tics do not respond sufficiently to conservative treatments or are functionally incapacitating ([@b57-ndt-4-1111]). The association of tics with medical or psychiatric conditions may necessitate more aggressive tic management. For example, TS has been associated with self-injurious behaviors requiring urgent medical attention ([@b118-ndt-4-1111]; [@b85-ndt-4-1111]; [@b87-ndt-4-1111]; [@b71-ndt-4-1111]; [@b6-ndt-4-1111]; [@b1-ndt-4-1111]), such as corneal and orbital injuries ([@b116-ndt-4-1111]) and stab wound- inflicted injuries ([@b6-ndt-4-1111]), or tic-induced medical complications, such as cervical myelopathy (Krauss and Jankovic 1996), limb fractures, and retinal detachments ([@b50-ndt-4-1111]). The variety of medications used to manage TS has included dopaminergic antagonists, benzodiazepines, calcium channel antagonists, and atypical neuroleptics ([@b83-ndt-4-1111]; [@b117-ndt-4-1111]; [@b76-ndt-4-1111]; [@b105-ndt-4-1111]). Botulinum toxin injections have been used to treat painful dystonic tics ([@b74-ndt-4-1111]). Medical therapies may be particularly useful even during the waning phase of tics in early adolescence since tics have been reported to worsen at that time before they may ultimately resolve ([@b89-ndt-4-1111]). However, medical therapies may cause detrimental and intolerable side effects ([@b90-ndt-4-1111]; [@b50-ndt-4-1111]) and, for a subset of patients with TS, are ineffective ([@b105-ndt-4-1111]; [@b150-ndt-4-1111]). As [@b79-ndt-4-1111] note, the development of additional treatment strategies for this subset of patients is particularly important given that the endpoint for unsatisfactorily managed neuropsychiatric disease is "dismal".

Pathophysiology of Tourette's syndrome
======================================

Anatomical studies
------------------

The development of surgical strategies for medically recalcitrant TS was enabled by efforts to localize an anatomical source of the symptoms. Psychodynamic theories prior to the 1970s sought to explain tics as resulting from suppressed aggression and "impaired functioning of the 'motility controlling function of the ego' " (Mahler and Luke 1946;Flinn et al 1983). Autopsy findings from patients with TS that demonstrated no specific anatomical pathologies or only subtle changes in the striatum seemed to support conceptions that tics had a psychogenic origin ([@b41-ndt-4-1111]; [@b14-ndt-4-1111]). The search for an anatomical basis for TS using autopsy material is thought to be problematic, however, both because few post-mortem brains have been studied and most of those available have come from patients with long-standing disease and treatment that might confound the histological analyses ([@b100-ndt-4-1111]; [@b53-ndt-4-1111]). Nevertheless, more recent studies have found abnormalities particularly in the basal ganglia and frontal cortex. For example, studies have reported decreased levels of dynorphin-like immunoreactivity in the striatum and globus pallidus ([@b62-ndt-4-1111]; [@b63-ndt-4-1111]), decreased subcortical levels of serotonin ([@b7-ndt-4-1111]), increased numbers of neurons expressing parvalbumin in the globus pallidus pars internus (GPi) and decreased numbers of neurons expressing parvalbumin in the caudate nucleus and globus pallidus pars externus (GPe) ([@b77-ndt-4-1111]). Interestingly, Itard had speculated that the symptoms of TS had a cerebral origin in his 1825 case report:

> What is the nature of these strange convulsions, or to pose the question in a clearer manner, the seat of the irritation which provokes them? Considering that the muscles which move against the will belong to different motor apparatuses which are not managed by the same nerves, this irritation is not caused by any of them but at their common centre which is the brain.

Neuroimaging studies
--------------------

Modern imaging studies lend further evidence for a neuroanatomic basis of TS. Asymmetric striatal volumes have been observed in magnetic resonance images (MRI) of patients with TS, with smaller striatal volumes suggesting abnormalities in striatal development or the loss of GABAergic interneurons that are thought to play a role in gating sensory information ([@b114-ndt-4-1111]; [@b131-ndt-4-1111]). Abnormally smaller caudate volumes are thought to be predictive of the development of more severe tics in early adulthood ([@b24-ndt-4-1111]) and have been associated with more severe symptoms in twin studies ([@b72-ndt-4-1111]). Abnormalities of volume also have been observed in the lenticular nuclei ([@b114-ndt-4-1111]; [@b131-ndt-4-1111]). These findings are inconsistent, however, since other studies have found no significant differences in basal ganglia nuclei volumes compared to those of normal control patients ([@b104-ndt-4-1111]; [@b155-ndt-4-1111]), or have found increased caudate volumes in children with TS ([@b40-ndt-4-1111]). Functional MRI has revealed activity in the neocortex, striatum, thalamus, parietal operculum, supplementary motor area, insular cortex, and cerebellum in association with tic generation ([@b115-ndt-4-1111]; [@b26-ndt-4-1111]; [@b91-ndt-4-1111]), while increased activity in the caudate and frontal and temporal cortices and decreased activity in the ventral GP, putamen and thalamus have been observed during tic suppression ([@b115-ndt-4-1111]). Increased activation of the substantia nigra, ventral tegmental area, and basal ganglia structures of the direct pathway has also been associated with increased tic severity in nonmedicated children with TS ([@b15-ndt-4-1111]). Positron emission tomography (PET) studies using ^18^F-fluorodeoxyglucose in patients with TS demonstrate increased metabolic activity in the premotor and supplementary cortices and midbrain and concomitant decreased activity in the caudate and thalamus ([@b137-ndt-4-1111]; [@b45-ndt-4-1111]) while in those studies using ^15^O-water found increased activity in cerebral regions associated with sensorimotor, language, executive and paralimbic functions, which was temporally related to both the expression of motor and phonic tics and their premonitory urges ([@b135-ndt-4-1111]). Finally, consistent with PET findings of decreased glucose utilization, single photon emission tomography (SPECT) has revealed decreased regional blood perfusion of the basal ganglia, thalamus, and frontal and temporal cortices in TS ([@b114-ndt-4-1111]).

Anatomic localization of TS symptom generation to the basal ganglia is consistent with current understanding of basal ganglia physiology. In a general sense, disordered cortico-striato-pallido-thalamo-cortical circuitry is thought to be etiologically-related to TS, although the specific nuclei and circuits responsible for the various symptoms remain a matter of continued investigation ([@b105-ndt-4-1111]; [@b101-ndt-4-1111]). It has been suggested, for example, that simple motor tics could be due to abnormal activation of the motor cortex via thalamocortical pathways while involvement of premotor, supplementary motor, and cingulate cortices may be related to more complex motor tics ([@b135-ndt-4-1111]; [@b100-ndt-4-1111]). Inappropriate activity in Broca's area, the frontal operculum, and the caudate nucleus could elicit vocal tics ([@b135-ndt-4-1111]; [@b100-ndt-4-1111]). Abnormal activation of the orbitofrontal region, which has been observed in obsessive compulsive disorder, may underlie the compulsions and urges that patients with TS experience ([@b135-ndt-4-1111]; [@b100-ndt-4-1111]). Alternatively, tics in TS may be due to abnormal activity within subsets of neurons within the caudate and putamen ([@b61-ndt-4-1111]; [@b100-ndt-4-1111]); indeed, microstimulation of discrete areas of the putamen in monkeys induces stereotypic movements akin to tics ([@b5-ndt-4-1111]).

Neurotransmitter studies
------------------------

Given the diversity of nuclei and circuits that may be involved in TS pathogenesis, the variety of neurotransmitter systems that are also implicated is not surprising ([@b75-ndt-4-1111]). In the frontal subcortical circuits alone, abnormalities in glutamate, dopamine, serotonin, GABA, acetylcholine, noradrenaline, opioid, and cannabinoid receptors are thought to be involved ([@b86-ndt-4-1111]). The serotonergic system has been studied in particular: patients with TS have been found to have decreased levels of serotonin and its metabolite 5-hydroxyindoleacetic acid in their serum ([@b35-ndt-4-1111]) and cerebrospinal fluid ([@b28-ndt-4-1111]), respectively, and post-mortem studies have found decreased serotonin levels in the brain stem ([@b142-ndt-4-1111]). This latter finding is particularly relevant since serotonergic projections from the medial raphe nucleus are known to project to regions implicated in tic generation, such as the prefrontal cortex, substantia nigra pars compacta, ventral tegmental area, striatum, and nucleus accumbens ([@b4-ndt-4-1111]; [@b113-ndt-4-1111]). These target structures are components of the dopaminergic system and, thus, it has been hypothesized that it is not serotonergic dysfunction, *per se*, that induces tics, but rather its effects on the dopaminergic system ([@b69-ndt-4-1111]). Serotonin influences dopaminergic release via a number of receptors, including serotonin heteroreceptors and inhibitory and stimulatory somatodendritic receptors, and is involved in dopamine reuptake ([@b125-ndt-4-1111]; [@b4-ndt-4-1111]; [@b113-ndt-4-1111]; [@b31-ndt-4-1111]).

Indeed, the most widely purported hypothesis to explain the etiology of TS concerns dopaminergic circuitry dysfunction. The ability of dopaminergic antagonists to suppress tics suggests that the dopaminergic system is hyperactive in TS ([@b75-ndt-4-1111]). The direct dopaminergic basal ganglia pathway is thus facilitated, and the indirect pathway inhibited, which results in thalamocortical over-activity ([@b150-ndt-4-1111]; [Figure 1](#f1-ndt-4-1111){ref-type="fig"}). Dopaminergic hyperactivity could arise due to alterations in dopamine release ([@b134-ndt-4-1111]; [@b130-ndt-4-1111]; [@b69-ndt-4-1111]). Imaging studies In TS suggest an "overactive DAT \[dopamine transporter\] system" ([@b69-ndt-4-1111]): for example, SPECT has demonstrated increased dopamine transporter binding in the striatum in patients with TS ([@b34-ndt-4-1111]; [@b124-ndt-4-1111]), suggesting an elevated density of presynaptic dopamine terminals and postsynaptic D2 dopamine receptors, particularly in the ventral striatum ([@b153-ndt-4-1111]; [@b46-ndt-4-1111]; [@b152-ndt-4-1111]; [@b3-ndt-4-1111]). In further study of D2 receptors using ^11^C raclopride PET, amphetamine challenge caused a 21% increase in intrasynaptic dopamine levels that was not observed in control patients ([@b132-ndt-4-1111]). Although D2 receptor density has correlated with TS symptom intensity in monozygotic twins ([@b152-ndt-4-1111]), this has not been consistently observed ([@b154-ndt-4-1111]). The net result of increased DAT density is decreased tonic extracellular levels of dopamine, increased dopamine levels in the axon terminal, and dopamine receptor supersensitivity (reviewed in [@b69-ndt-4-1111]). Alternatively, TS may result not from abnormalities of dopaminergic transmission but from changes in the resting membrane potentials of striatal neurons whose response to dopamine is consequently affected ([@b100-ndt-4-1111]).

Animal studies
--------------

Animal models have been developed to better understand the pathophysiologic basis of TS ([@b140-ndt-4-1111], [@b141-ndt-4-1111]). Normally, a prestimulus can prevent a startle response elicited by a stimulus, but this has been found to be deficient in TS ([@b32-ndt-4-1111]; [@b52-ndt-4-1111]). This is thought to be due to deficient "gating" of sensorimotor information and has been modelled in rodents, pigs, and nonhuman primates ([@b139-ndt-4-1111]; [@b140-ndt-4-1111]; [@b52-ndt-4-1111]; [@b64-ndt-4-1111]). In order to model the hyperactive basal ganglia and limbic circuitry thought to underlie TS, transgenic mice have been developed that have tonically hyperactive cortical and limbic circuits ([@b29-ndt-4-1111]; [@b98-ndt-4-1111]; [@b108-ndt-4-1111]; [@b140-ndt-4-1111],2007). These rodents display tics as well as compulsive behaviors ([@b29-ndt-4-1111]; [@b98-ndt-4-1111]; [@b108-ndt-4-1111]; [@b140-ndt-4-1111], 2007). Micro- injection of the GABA~A~ antagonist bicuculline in the limbic area of the GPe has also been shown to induce complex tics and compulsions in African green monkeys and may therefore provide an additional primate model of TS ([@b60-ndt-4-1111]). In addition to enhancing understanding of abnormal TS neural circuitries, animal models could be used to test surgical therapies before they are introduced to the clinical setting.

Neurosurgical lesions
=====================

Frontal lobe disconnection
--------------------------

Surgical disruption of basal ganglia circuits began to be employed for the treatment of TS in 1955 ([@b136-ndt-4-1111]; [Figure 2](#f2-ndt-4-1111){ref-type="fig"}, [Table 1](#t1-ndt-4-1111){ref-type="table"}). The earliest studies focused on surgical disconnection of the frontal lobe. [@b136-ndt-4-1111] reported the details of the prefrontal lobotomy that James Watts had performed nine years earlier in a 37-year-old man who had become incapacitated due to his motor and vocal tics. Two years post-operatively, the patient demonstrated improvement in his symptoms, which persisted for at least an additional six years. His beneficial clinical course could not be attributed entirely to the surgery, however, since he also began to use neuroleptics. [@b12-ndt-4-1111] reported the apparently successful management of tics and panic attacks in a 22-year-old man with bimedial frontal leucotomy, but [@b102-ndt-4-1111] found that these benefits did not persist. The longest reported duration of symptom control attributed to prefrontal leucotomy was that experienced by a 29-year-old man with TS in whom there was complete resolution of motor and vocal tics beginning five years post-operatively and for thirty-three years thereafter ([@b82-ndt-4-1111]). Measurement of regional cerebral blood flow using ^99^Tc-hexamethlypropylene amine oxide SPECT showed bilateral frontal hypoperfusion ([@b82-ndt-4-1111]).

Cingulotomy
-----------

Demonstration of the efficacy of frontal lobotomy procedures for TS was not clear, and as a result procedures that targeted the cingulate cortex were investigated as an alternative. Anterior cingulotomy had been used since 1948 to treat a variety of psychiatric disorders to disconnect neural circuits involving the cortex, limbic system, and basal ganglia ([@b151-ndt-4-1111]; [@b13-ndt-4-1111]). Targeting the cingulate cortex for the treatment of TS seemed appropriate given its recognized role in mediating emotional experiences and language and coordinated movements ([@b116-ndt-4-1111]). Cingulotomy decreased tics by 75% by 2 years post-operatively in one patient ([@b6-ndt-4-1111]) and provided enduring improvement in another ([@b123-ndt-4-1111]). In an imaging study that found normalization of preoperative hypermetabolism in the caudate nucleus and thalamus, the beneficial effects of cingulotomy were ascribed nonspecifically to the disruption of abnormal basal ganglia-thalamocortical circuitry ([@b123-ndt-4-1111]). Other case reports have not confirmed those beneficial effects of cingulotomy and found that the procedure had little effects on reducing either tic severity or frequency or seemed more efficacious for other comorbid symptoms, such as SIB and OCD ([@b84-ndt-4-1111], [@b85-ndt-4-1111]; [@b116-ndt-4-1111]; [@b11-ndt-4-1111]). [@b17-ndt-4-1111] has recommended against the use of cingulotomy because of its side effects, which have included the development of apathy, intellectual impairment, and difficulties with concentration.

Thalamotomy
-----------

Attenuation of the corticostriatal hyperactivity that is thought to underlie TS symptomatology has also been attempted by thalamic lesions. Cooper's performance of a right and then, one year later, left chemothalamectomy in a 16-year-old girl with TS significantly improved her tic frequency (Cooper 1962) and he later described his experience with thalamic lesions in six other patients with TS (Cooper 1969). Details for only one representative case were provided, in which surgery had no effect on the tics. The results of [@b70-ndt-4-1111] were more promising: up to 14 coagulations were made stereotactically in each hemisphere in the medial, intralaminar, and ventrolateral thalamic nuclei and between 70% and 100% subjective improvement of tic symptomatology was observed. The same nuclei have been targeted in 4 other reported patients, but complete tic resolution was observed in only one patient, and in the others tic improvement was only transient at best ([@b38-ndt-4-1111]; [@b30-ndt-4-1111]). A case report in which bilateral cingulotomies and infrathalamic lesions were made highlights the potential devastating complications of thalamic lesions ([@b87-ndt-4-1111]). A 40-year-old man who underwent these procedures demonstrated improvement of obsessive compulsive symptoms but persistence of motor and vocal and the left lesions were therefore repeated ([@b87-ndt-4-1111]). The infrathalamic lesion was extended inferiorly within the red nucleus and included as well the H fields of Forel, the basal intralaminar nucleus of the thalamus, the subthalamic nucleus, efferent fibres from the VTA and SNr, and the dentatorubrothalamic efferent fibres from the cerebellum ([@b87-ndt-4-1111]). Post-operatively the patient developed a number of severe neurological deficits including dysarthria, dysphagia, gait and hand-writing difficulties, mild hemiparesis, abnormal extraocular movements, axial rigidity, and bradykinesia ([@b87-ndt-4-1111]).

Lesions of other structures
---------------------------

Stereotaxy has facilitated the targeting of other deep-seated cerebral structures for the treatment of TS. In combination with lesions of the lamella medialis and ventrolateral nuclei of the thalamus, the zona incerta has been lesioned with significant reduction of tic severity ([@b10-ndt-4-1111]). Transient and permanent deficits were experienced by 66% and 27% of patients ([@b10-ndt-4-1111]), with bilateral lesions carrying a higher risk of neurological morbidity, including hemiballism, dystonia, dysarthria ([@b10-ndt-4-1111]), and quadriplegia ([@b9-ndt-4-1111]). Other structures targeted include the anterior limb of the internal capsule ([@b138-ndt-4-1111]), within which striatal circuits and circuits that connect orbitofrontal cortical and medial thalamic nuclei pass. Lesions of the posterior third of the anterior internal capsule provided more durable improvement of symptoms, which was thought to be due the greater efficacy of posterior lesions to disrupt neural pathways connecting the basal ganglia and frontal cortex ([@b138-ndt-4-1111]). In one case report, lesions of the dentate nucleus reportedly attenuated motor and vocal tics, but neither rationale for targeting this cerebellar structure nor a proposed mechanism of beneficial action were discussed ([@b106-ndt-4-1111]).

Deep brain stimulation
======================

Although neurosurgical lesions for TS have ameliorated symptoms for some patients, for others, benefits have not been apparent and lesions have been associated with a number of permanent and disabling side effects. Deep brain stimulation (DBS) emerged as a promising alternative therapeutic strategy to stereotactic lesions after its efficacy in the treatment of tremor was demonstrated in 1987 ([@b18-ndt-4-1111]). The similar clinical effects of lesions and high frequency stimulation (HFS) suggest that DBS may inhibit the activity of target structures, by depolarization blockade, synaptic inhibition, and/or the release of inhibitory neurotransmitters ([@b20-ndt-4-1111]; [@b44-ndt-4-1111]; [@b48-ndt-4-1111]; [@b94-ndt-4-1111]; [@b99-ndt-4-1111]; [@b33-ndt-4-1111]; [@b93-ndt-4-1111]; [@b103-ndt-4-1111]). Other studies suggest, however, that DBS has an excitatory effect on neurons and axonal pathways in the vicinity of the electrode ([@b99-ndt-4-1111]; [@b33-ndt-4-1111]; [@b93-ndt-4-1111]; [@b103-ndt-4-1111]), or that DBS works by modulating the pattern of neuronal firing ([@b54-ndt-4-1111]; [@b56-ndt-4-1111];Change et al 2008; [@b93-ndt-4-1111]; [@b103-ndt-4-1111]). Regardless of its mechanism of action, compared to lesion procedures DBS has the advantage of being both reversible (since the electrodes can be removed if HFS ineffectively treats symptoms) and adjustable (since the stimulation parameters can be varied to elicit the most optimal clinical response). [@b19-ndt-4-1111] has thus referred to DBS as a "flexible scalpel."

Thalamic stimulation
--------------------

Based upon the reported success of thalamic lesions in the control of TS symptoms, [@b149-ndt-4-1111] performed HFS of the thalamus in a 42-year-old man with medically recalcitrant TS ([Table 2](#t2-ndt-4-1111){ref-type="table"}). They found that HFS of the thalamic targets of [@b70-ndt-4-1111] significantly reduced the number of tics by 4 months post-operatively, with complete resolution of the tics after 1 year. Clinical benefits were ascribed to deactivation of frontal cortical areas (via stimulation of the nucleus ventro-oralis internus) and corticostriatal circuits that involve the ventral (limbic) and dorsal (sensorimotor) striatum (via stimulation of intralaminar and medial thalamic nuclei). In a subsequent study in which three patients were followed up to five years post-operatively, thalamic DBS was associated with a 72%, 83%, and 90% decrease in tics with complete resolution of all major vocal and motor tics ([@b148-ndt-4-1111]). Side effects of HFS included a slight sedative effect in all three patients and changes in sexual behavior in two ([@b148-ndt-4-1111]). [@b126-ndt-4-1111] confirmed the therapeutic efficacy of thalamic DBS, albeit using targets different than those used by Visser-Vandewalle and colleagues, in their case series of eighteen patients in whom the centromedian-parafascicular and ventral oral thalamic nuclei were targeted. All patients demonstrated improvement in all four components of the Yale Global Tic Severity Rating Scale (YGTSS). By six months post-operatively, 3 patients' tics had improved to the extent that they no longer required any adjunctive medical therapy. None of the patients experienced any disabling permanent side effects, but twelve patients required HFS adjustments. The ability for the effects of DBS to be tested in a double-blind manner was utilized in a recent prospective crossover trial ([@b96-ndt-4-1111]). Patients in whom bilateral thalamic DBS electrodes were implanted were assessed over four weeks, with one week spent in each of the following DBS states: both stimulators off, unilateral stimulation on the left or right, or bilateral stimulation ([@b96-ndt-4-1111]). The study's primary and secondary outcome measures were met in that all patients demonstrated significant improvements in Rush Video-Based Rating Scale (RVBRS) scores as well as YGTSS and TS Symptom List scores ([@b96-ndt-4-1111]). [@b1-ndt-4-1111] case report highlights that significant adverse effects can occur due to the thalamic DBS. Their 39-year-old patient developed a vertical gaze paralysis due to hemorrhage in the upper mesencephalon at the caudal tip of one of the electrodes.

Pallidal stimulation
--------------------

Attenuation of thalamic activity, indirectly, has also been attempted by HFS of the GPi in order to inhibit its pathological over-activity that is thought to ultimately lead to disinhibition of the thalamus and, thus, tics ([@b146-ndt-4-1111]; [@b42-ndt-4-1111]; [@b71-ndt-4-1111]; [@b2-ndt-4-1111]; [@b55-ndt-4-1111]; [@b127-ndt-4-1111]). [@b146-ndt-4-1111] found that bilateral GPi DBS decreased tics by 95% in a 27-year-old man with long-standing TS, which was greater than the suppression of tics induced by medial thalamic DBS (80%), an effect that lasted at least six months. The efficacy of thalamic or pallidal DBS was found to be similar in another case report, although tic attenuation occurred more abruptly with pallidal stimulation ([@b2-ndt-4-1111]). [@b71-ndt-4-1111] also directly compared the efficacy of pallidal versus thalamic DBS in their prospective double blind study. In one patient in whom electrodes were placed in the anteromedial GPi and centromedian-parafascicular complex of the thalamus, either thalamic or pallidal stimulation significantly reduced tic severity and SIB to a similar extent. Symptoms relating to mood and impulsivity were better controlled by thalamic DBS, however. [@b42-ndt-4-1111] provide up to fourteen months of follow-up data regarding their patient with bilateral DBS of the posteroventrolateral GPi. Tic frequency and intensity improved, as did the patient's concomitant anxious and depressive symptoms. These beneficial effects have been observed in two other case reports ([@b55-ndt-4-1111]; [@b127-ndt-4-1111]).

Other targets for stimulation therapy
-------------------------------------

Other less frequently targeted structures include the anterior limb of the internal capsule and the nucleus accumbens ([@b50-ndt-4-1111]; [@b81-ndt-4-1111]). Using a more lateral and anterior target than has been used for the surgical treatment of OCD, DBS of the anterior limb of the internal capsule has been shown to decrease tic severity and frequency, but not to the extent that has been observed with thalamic DBS ([@b50-ndt-4-1111]). Stimulation of the electrode's middle contacts resulted in the greatest improvement of tic symptomatology ([@b50-ndt-4-1111]). Interestingly, variation in voltage parameters affected the patient's mood: HFS in the middle or dorsal-most contacts, which lay in the body of internal capsule, produced euthymia and hypomania, respectively, whereas stimulation of the ventral-most contacts, which was located near the nucleus accumbens, caused depression ([@b50-ndt-4-1111]). [@b81-ndt-4-1111] did not report any alteration of mood in their case report of HFS of the anterior limb of the internal capsule and fundus subventricularis of the nucleus accumbens, and found that it decreased their 26-year-old patient's YGTSS and RVBRS scores by 41% and 50%, respectively.

DBS caveats
-----------

Despite their therapeutic promise for TS and apparent advantages compared with neurosurgical lesion procedures, DBS strategies also can be associated with a number of deleterious side effects and complications. While certain adverse events are common to both lesion and DBS procedures, such as intracerebral hemorrhage[1](#fn1-ndt-4-1111){ref-type="fn"} and the development of surgery-related infection or seizures ([@b68-ndt-4-1111]), others are unique to DBS. For example, patients with TS in whom DBS systems have been implanted have experienced poor healing, infections, or hardware malfunctions due to compulsions to repeatedly touch their incisions or push on the subcutaneously-buried hardware ([@b126-ndt-4-1111]; [@b127-ndt-4-1111]; [@b129-ndt-4-1111]). [@b92-ndt-4-1111] suggest that patients with comorbid OCD symptoms may become obsessed with their DBS systems in terms of thoughts of "mind control". Moreover, DBS requires ongoing surgical maintenance to replace pulse generators ([@b23-ndt-4-1111]), which last between several months to five years depending upon stimulation parameters, manage hardware-related complications ([@b110-ndt-4-1111]; [@b143-ndt-4-1111]; [@b37-ndt-4-1111]; [@b65-ndt-4-1111]), which have been noted to occur in up to 26% of cases, or adjust the stimulation settings. As has been reported for patients who have received DBS for Parkinson's disease, HFS for TS may induce or exacerbate pre-existing psychiatric symptoms ([@b8-ndt-4-1111]).

Surgical considerations
=======================

With DBS emerging as a promising therapeutic strategy for the management of TS, guidelines have been proposed regarding its use ([@b101-ndt-4-1111]; [@b68-ndt-4-1111]; [@b111-ndt-4-1111]). Since TS symptoms, especially motor symptoms, may dissipate in late adolescence ([@b89-ndt-4-1111]), it has been suggested that surgical candidates be at least twenty-five years of age, although [@b101-ndt-4-1111] acknowledge that selection of that age is somewhat arbritary. Patient selection should occur in a standardized manner. Patients should have their diagnosis of TS confirmed by two independent clinicians and demonstrate recalcitrance to nonsurgical therapies ([@b133-ndt-4-1111]; [@b101-ndt-4-1111]; [@b150-ndt-4-1111]). [@b150-ndt-4-1111] suggests that this entails a lack of, or at best only partial, response to three different classes of medications (antidopaminergic, anti-psychotic, and experimental agents) and behavioral therapies. Patients should have tics severe enough to significantly impair quality of life and/or pose medical risk, and this is suggested to correspond to a YGTSS total tic severity score of \>35/50 for at least one year (which corresponds to tics that are frequent and noticeable in most situations most of the time) ([@b101-ndt-4-1111]). Patients unsuitable for surgical management include those who have a disorder other than TS, other severe psychiatric co-morbidities, structural cerebral abnormalities, or who have medical contraindications to undergoing surgery ([@b101-ndt-4-1111]; [@b150-ndt-4-1111]). It is mandatory that an ethics review board oversee DBS clinical trials and that a multidisciplinary team provides ongoing input into clinical trial design and evaluation ([@b49-ndt-4-1111]; [@b109-ndt-4-1111]; [@b57-ndt-4-1111]; [@b66-ndt-4-1111]). Patients should be assessed using validated and standardized tests ([@b105-ndt-4-1111]), such as the YGTSS ([@b67-ndt-4-1111]), RVBRS, Shapiro TS Severity Scale ([@b128-ndt-4-1111]), and TS Symptom List ([@b88-ndt-4-1111]), as well as a battery of neuropsychological tests ([@b101-ndt-4-1111]; [@b150-ndt-4-1111]). Preoperatively, MRI should be performed to facilitate stereotactic planning and post-operatively, imaging is mandatory to confirm electrode placement ([@b101-ndt-4-1111]). This would additionally provide visualization of the centre of the active contact of stimulation, the positioning of which is crucial to avoid DBS failure ([@b112-ndt-4-1111]). Since insertion of DBS electrodes can cause a microlesion effect ([@b71-ndt-4-1111]), post-operative assessments of DBS efficacy should be performed after these possible effects have resolved and after stimulation parameters have stabilized ([@b150-ndt-4-1111]). Assessment of DBS effects is recommended to be performed in a double-blind fashion. Since DBS for TS remains an experimental therapy, its performance should be limited to neurosurgical centres with DBS experience in the treatment of movement disorders and with collaborations with neurological and psychiatric services ([@b150-ndt-4-1111]; [@b147-ndt-4-1111]). As is standard with other therapies, patients must be able to provide informed consent to participate in clinical trials and should be allowed to withdraw from DBS management at any time ([@b101-ndt-4-1111]; [@b109-ndt-4-1111]). The aim of DBS for TS is solely to relieve patients of their symptoms and not for political, law enforcement, or social purposes ([@b78-ndt-4-1111]).

Conclusions
===========

> In any scientific treatment which is not fully understood there is the serious danger of not being able to predict possible damage. It should be an inflexible duty to become thoroughly familiar with the drug or procedure to be employed. This implies a thorough understanding of the physiological and psychobiological functions which may have a bearing on the proposed treatment ([@b43-ndt-4-1111]).

Oskar [@b43-ndt-4-1111] advice at that 1938 Annual Meeting of the American Psychiatric Association bears relevance even seventy years later. Neurosurgical lesion procedures and DBS have demonstrated therapeutic promise for a subset of patients with TS but have not yet provided sufficient evidence to justify their use as standard therapies for TS. Lesion studies provided the proof-of-principle that TS symptoms could be treated using surgery to target specific cerebral structures, but are limited by methodologic issues in study design, such as their open-label nature (see [Table 1](#t1-ndt-4-1111){ref-type="table"}), unclear patient inclusion and exclusion criteria, and lack of post-operative assessment of the size and location of the lesions performed. To date, most surgical experiences with DBS also have been described in open-label case reports or series with varying degrees of success and with inconsistency in the types of post-operative assessments performed ([@b144-ndt-4-1111]; [@b107-ndt-4-1111]). Ultimately, improvement of the efficacy of surgical strategies for TS will require identification of the patients whose tics are most likely to respond to HFS, performing comprehensive pre-and post-operative blinded and standardized clinical assessments of tic symptoms, and determination of the most appropriate surgical target(s) for resolution of tic symptomatology. It is anticipated that the development of animal models of TS as well as further advances in anatomical and functional imaging technologies will enhance understanding of TS pathophysiology and so lead to the refinement of current surgical strategies ([@b120-ndt-4-1111]; [@b121-ndt-4-1111]).
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The reported incidence of symptomatic intracerebral hemorrhage associated with stereotactic procedures ranges from 0.6% to 2.1%, with age, male sex, Parkinson's disease, and hypertension found to be significant risk factors ([@b21-ndt-4-1111]; [@b47-ndt-4-1111]; [@b95-ndt-4-1111]; [@b22-ndt-4-1111]; [@b59-ndt-4-1111]; [@b122-ndt-4-1111]). It has been found that the incidence of intracerebral hemorrhage following either thalamic DBS or ablative thalamic lesions for parkinsonian tremor is not significantly different ([@b25-ndt-4-1111]).

![Schematic representation of basal ganglia circuitry (modified from Visser-Vandewalle et al 1997), with excitatory (glutamatergic) projections ![](ndt-4-1111f3.jpg) and inhibitory (GAB-Aergic) projections →. Normally, dopamine, acting via D1 dopamine receptors, has an excitatory influence on striatal projections to the GPi and, acting via D2 dopamine receptors, an inhibitory influence on striatal projections to the GPe, maintaining a balance between the activities of the direct and indirect basal ganglia pathways. According to the dopaminergic hypothesis of TS pathophysiology, dopaminergic hyperactivity causes increased activity in the direct pathway (indicated by the heavier weighted lines) and decreased activity in the indirect pathway, which serves to enhance thalamocortical activity. In TS, the thalamus, caudate-putamen, and GPe become pathologically hyperactive, and the GPi and STN become pathologically hypoactive.\
**Abbreviations:** GPi, globus pallidus pars internus; GPe, globus pallidus pars externus; STN, subthalamic nucleus; DA, dopamine.](ndt-4-1111f1){#f1-ndt-4-1111}

![Sagittal magnetic resonance image demonstrating the sites of lesions for TS.\
**Notes:** 1, frontal leucotomy; 2, cingulotomy; 3, zona incerta lesion; 4, thalamotomy; 5, hypothalamotomy; and 6, dentatotomy.](ndt-4-1111f2){#f2-ndt-4-1111}

###### 

Clinical studies of neurosurgical lesions for Tourette's syndrome

  Study effects                                  Study design   n    Comorbid diagnoses     Lesion                                                                                                                                                                              Outcomes                                                                                                                                                                                                                                                                                                                                                                Adverse
  ---------------------------------------------- -------------- ---- ---------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b12-ndt-4-1111]                              Case report    1    anxiety                Bimedial frontal leucuotomy                                                                                                                                                         Follow-up: 1 year                                                                                                                                                                                                                                                                                                                                                       frontal lobe abscess
                                                                                                                                                                                                                                                                                tics and panic attacks "markedly reduced"                                                                                                                                                                                                                                                                                                                               
  [@b136-ndt-4-1111]                             Case report    1    --                     Transorbital lobotomy                                                                                                                                                               Follow-up: 9 years                                                                                                                                                                                                                                                                                                                                                      obesity
                                                                                                                                                                                                                                                                                significant decrease in frequency, duration, and amplitude of tics                                                                                                                                                                                                                                                                                                      
  [@b70-ndt-4-1111]                              Case series    3    OCD                    Thalamotomy (bilaterally; targeted rostral intralaminar and medial nuclei)                                                                                                          Follow-up: time not specified                                                                                                                                                                                                                                                                                                                                           mood alterations
                                                                                                                                                                                                                                                                                Evaluation: techniques not specified70%--100% improvement of coprolalia and tics                                                                                                                                                                                                                                                                                        
  [@b106-ndt-4-1111]                             Case report    1    not indicated          Dentatotomy (bilateral)                                                                                                                                                             Follow-up: time not specified                                                                                                                                                                                                                                                                                                                                           none reported
                                                                                                                                                                                                                                                                                decrease in motor tics and resolution of vocal tics                                                                                                                                                                                                                                                                                                                     
  [@b38-ndt-4-1111]                              Case series    3    OCD                    Thalamotomy (unilateral, except for 1 patient who also received a contralateral thalamotomy)                                                                                        Follow-up: at least 1 year (exact time not specified)                                                                                                                                                                                                                                                                                                                   "prolonged mental confusion" (1 patient)
                                                                                                                                                                                                                                                                                complete remission of tics for \>1 year but then recurrence of symptoms 2 patients)no improvement of tics (1 patient)                                                                                                                                                                                                                                                   
  [@b84-ndt-4-1111]                              Case series    2    OCD                    Cingulotomy                                                                                                                                                                         Follow-up: time not specified                                                                                                                                                                                                                                                                                                                                           none reported
                                                                                                                                                                                                                                                                                transient improvement of ticsslight improvement of ritualistic behavior                                                                                                                                                                                                                                                                                                 
  [@b85-ndt-4-1111]                              Case series    2    OCD                    Cingulotomy (bilateral anterior; 1 patient had procedure repeated 8 months after first)                                                                                             Follow-up: up to 2 years                                                                                                                                                                                                                                                                                                                                                aseptic meningitis for patient who underwent two procedures
                                                                                                                                                                                                                                                                                Evaluation: clinical rating scales not utilizedNo effects on tics or coprolalia                                                                                                                                                                                                                                                                                         
  [@b116-ndt-4-1111]                             Case report    1    SIB                    Cingulotomy (bilateral)                                                                                                                                                             Follow-up: 2 years                                                                                                                                                                                                                                                                                                                                                      mild apathy
  intellectual impairment                                                                                                                                                                                                                                                       Evaluation: LOI, BDI                                                                                                                                                                                                                                                                                                                                                    general intellectual impairment
  difficulties with organization concentration                                                                                                                                                                                                                                  75% ↓ severity of tics                                                                                                                                                                                                                                                                                                                                                  
  [@b87-ndt-4-1111]                              Case report    1    OCD                    Cingulotomy (bilateral anterior) and infrathalamic lesion (bilateral)                                                                                                               Follow-up: 16 months                                                                                                                                                                                                                                                                                                                                                    sepsis
                                                                                            Left cingulated and infrathalamic lesions repeated 1 month later                                                                                                                    Evaluation: YBOCS, YGTSSimprovement in tics (YGTSS score ↓ from 22 to 15)                                                                                                                                                                                                                                                                                               dysarthria, dysphagia, dysphoniasevere handwriting problems, micrographia
  [@b123-ndt-4-1111]                             Case report    1    OCD, SIB               Hypothalamus (anterior) and cingulotomy (inferior)                                                                                                                                  Follow-up: 21 months                                                                                                                                                                                                                                                                                                                                                    none reported
                                                                                                                                                                                                                                                                                by 19 months no clinical signs of Tourette's syndrome                                                                                                                                                                                                                                                                                                                   
  [@b11-ndt-4-1111]                              Case report    1    OCD                    Cingulotomy (second cingulotomy performed 18 months after the first)                                                                                                                Follow-up: 18 months (first cingulotomy); 13 months (second cingulotomy)                                                                                                                                                                                                                                                                                                none reported
                                                                                                                                                                                                                                                                                Evaluation: YBOCS, BDI, CGI scaleby 18 months following 1st surgery, depression and anxiety improved, but OCD and tics not improvedby 13 months following 2nd surgery, OCD, depression, and anxiety improved, but tics worse                                                                                                                                            
  [@b82-ndt-4-1111]                              Case report    1    OCD                    Leucotomy (bilateral prefrontal)                                                                                                                                                    Follow-up: 39 years                                                                                                                                                                                                                                                                                                                                                     bulimia, weight gain, compulsive smoking appeared 4 years after surgery and deemed to be surgical
                                                                                                                                                                                                                                                                                Evaluation: YBOCS, LOI, HDRS TBSA, TSGSDisappearance of coprolalia, copropraxia, and OCD 5 years after surgery that recurred 38 years later                                                                                                                                                                                                                             surgical side effects
  Korzenev et al 1997                            Case series    4    OCD                    Details regarding the lesion targets, follow-up period, evaluation techniques and effects on tics not specified                                                                                                                                                                                                                                                                                                                                                                                                                                             
  [@b10-ndt-4-1111]                              Case series    16   ADHD (3 patients)      ZI, LM, VL                                                                                                                                                                          Follow-up: 7 years (range 3.5--17 years) (11 patients); 5 patients lost to follow-up                                                                                                                                                                                                                                                                                    Cerebellar signs, dystonia, and dysarthria (11 patients)
                                                                                            9 patients -- bilateral lesions                                                                                                                                                     Evaluation: Tic severity rating scale                                                                                                                                                                                                                                                                                                                                   transient postoperative morbidity (6 patients)
                                                                                            ZI targeted in 15 patients                                                                                                                                                          significant improvement of both vocal and motor tic scores (33%--75% and 25%--80% in tic severity reduction, respectively)                                                                                                                                                                                                                                              hemiparesis (3 patients)
                                                                                            ZI and VL/LM in 11 patients                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 disabling hemiballism (1 patient)
  [@b6-ndt-4-1111]                               Case report    1    SIB, OCD, ADHD         Cingulotomy (targeted area above corpus callosum) and urinating then limbic leucotomy (7 months afterwards, targeted area under caudate nucleus proximal to previous lesion site)   Follow-up (cingulotomy): 6 months                                                                                                                                                                                                                                                                                                                                       Cingulotomy: headaches, difficulty
                                                                                                                                                                                                                                                                                initial period of improvement of SIB but then recurrence of tics and SIBFollow-up (leucotomy): not specified↓ frequency and severity of SIB                                                                                                                                                                                                                             Leucotomy headaches, drowsiness
  [@b138-ndt-4-1111]                             Case series    12   OCD SIB (4 patients)   Capsulotomy \[targeted the anterior 1/3 (7 patients) or posterior 1/3 (5 patients) of anterior internal capsule\], bilaterally                                                      Follow-up: 3--18 months (mean 13.4)                                                                                                                                                                                                                                                                                                                                     no severe, permanent side effects
                                                                                                                                                                                                                                                                                Reduction of tics immediately post-operatively after anterior internal capsule lesion; benefits decreased by 1 months post-operatively in 5 patients; only 2 patients demonstrated 80% ↓ in tics over sustained time period4 patients with lesion of posterior internal capsule demonstrated significant and sustained reduction of tics; 1 patient had 50% ↓ of tics   transient urinary incontinence, memory complaints, confusiondelayed side effects: increased sexual behavior (3 patients), immature behavior (2 patients), akathisia (2 cases)

**Abbreviations:** ADHD, attention deficit hyperactivity disorder; BDI, beck depression inventory; CGI, clinical global improvement scale; HDRS, hamilton depression rating scale; LM, lamella medialis thalamus; LOI, leyton obsessional inventory; OCD, obsessive-compulsive disorder; SIB, self-injurious behaviour; TBSA, tyrer brief scale for anxiety; TSGS, tourette's syndrome global scale; VL, ventrolateral nuclei of the thalamus; YBOCS, yale-brown obsessive compulsive scale; ZI, zona incerta.

###### 

Clinical studies of deep brain stimulation for Tourette's syndrome

  Study                Study design                                       n    Comorbid diagnoses                                                           DBS target(s)                                                                                    Outcomes                                                                                                                                                                                                                                                                                         Adverse effects
  -------------------- -------------------------------------------------- ---- ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@b149-ndt-4-1111]   Case report                                        1    --                                                                           Thalamus (rostral intralaminar and medial nuclei) bilaterally                                    Follow-up: 1 year                                                                                                                                                                                                                                                                                none reported
                                                                                                                                                                                                                                                             Evaluation: videotape analysis of ticscomplete abolishment of tics                                                                                                                                                                                                                               
  [@b146-ndt-4-1111]   Case report                                        1    depression                                                                   Thalamus (medial) and GPi bilaterally                                                            Follow-up: 6 months                                                                                                                                                                                                                                                                              none reported
                                                                                                                                                                                                                                                             Evaluation: not specified80% ↓ tics by thalamic DBS95% ↓ tics by pallidal DBS                                                                                                                                                                                                                    
  [@b148-ndt-4-1111]   Case series                                        3    --                                                                           Thalamus (at level of the Voi, Cm, Spv) bilaterally                                              Follow-up: 8 months -- 5 years                                                                                                                                                                                                                                                                   reduced energy at stimulus voltage required for optimal tic management
                                                                                                                                                                                                                                                             Evaluation: videotape analysis of ticsResolution of all major tics                                                                                                                                                                                                                               increased sexual drive (1 patient)reduced sexual function (1 patient)3 revisions of pulse and cables because of pain generator traction (2 patients)
  [@b50-ndt-4-1111]    Case report                                        1    --                                                                           AIC (ventral) bilaterally                                                                        Follow-up: 18 months                                                                                                                                                                                                                                                                             mood alteration (high nucleus voltage stimulation at depression accumbens produced at and apathy, stimulation capsule in body of internal produced hypomania)
                                                                                                                                                                                                                                                             Evaluation: YGTSS25% ↓ YGTSS in overall impairment17% ↓ total tic score20% ↓ global severity45% ↓ tic severity and frequency and increased ability to suppress tics (according to patient)                                                                                                       
  [@b42-ndt-4-1111]    Case report                                        1    mild OCD                                                                     GPi bilaterally                                                                                  Follow-up:14 months                                                                                                                                                                                                                                                                              transient fatigue (several months)
                                                                                                                                                                                                                                                             Evaluation: YGTSS, BDI, STAI, SCL-90-R73% ↓ tic frequency/minute↓ intensity of vocal tics                                                                                                                                                                                                        impaired rapidly alternating pronation and supination movements of left limbs
  [@b71-ndt-4-1111]    Prospective double blind                           1    Anxiety Depression SIB                                                       Ce-Pf of thalamus, GPi, or both                                                                  Follow-up: 2 years                                                                                                                                                                                                                                                                               weight loss
                                                                                                                                                                                                                                                             Evaluation: YGTSS, RVB- TRS, MADRS, BAS, BISThalamic DBS: 64% ↓ YGTSS scores, 77% ↓ RVBTS scoresPallidal DBS: 66% ↓ YGTSS scores, 54% ↓ RVBTS scorescombined DBS: 60% ↓ YGTSS scores, 77% ↓ RVBTS scoreselimination of SIB                                                                       
  [@b2-ndt-4-1111]     Case series                                        2    OCD                                                                          Patient 1: Thalamus (at level of Voi, Cm, and Spv) bilaterally                                   Follow-up: 1 year                                                                                                                                                                                                                                                                                feeling of ↓ energy at required stimulus voltage reduction for optimal tic
                                                                                                                                                                                                                                                             Evaluation: Videotaping and counting tics                                                                                                                                                                                                                                                        ↓ sexual functions
                                                                                                                                                            Patient 2: Thalamus (at level of Voi, Cm, and Spv) and GPi (postero ventrolateral) bilaterally   ↓ tics \[from 20 to 3/minute (patient 1) and 28 to 2/minute (patient 2)\]                                                                                                                                                                                                                        dystonic jerk when stimulator activated
                                                                                                                                                                                                                                                             Complete resolution of all major tics and compulsions                                                                                                                                                                                                                                            
  [@b55-ndt-4-1111]    Case report                                        1    --                                                                           GPi bilaterally                                                                                  Follow-up: "months" (time not specified)                                                                                                                                                                                                                                                         Infection of stimulator lead
                                                                                                                                                                                                                                                             evaluation of tics not discussed                                                                                                                                                                                                                                                                 
  [@b1-ndt-4-1111]     Case report                                        1    SIB                                                                          Thalamus (medial part at crosspoint of Cm, Voi, hemorrhage and Spv) bilaterally                  effects on tics not discussed                                                                                                                                                                                                                                                                    vertical gaze palsy due to intracerebral
  [@b81-ndt-4-1111]    Case report                                        1    OCD                                                                          nucleus accumbens and anterior limb of the internal capsule                                      Follow-up: 2.5 years                                                                                                                                                                                                                                                                             none reported
                                                                                                                                                                                                                                                             Evaluation:YGTSS, MRVRS, GAF, YBOCS41%, 50%, and 52% remission rates in YGTSS, MRVRS, and YBOCS, respectivelyconsiderable improvement in psycho-social functioning (GAF ↑from 7 to 41)                                                                                                           
  [@b96-ndt-4-1111]    Prospective, randomized, double-blind, crossover   5    ADHD (3 patients) OCD (4 patients) depression (5 patients)                   Thalamus (Cm, Voi, and Spv) bilaterally                                                          Follow-up: 3 months                                                                                                                                                                                                                                                                              none related to the procedures
                                                                                                                                                                                                                                                             Evaluation: YGTSS, SF-36, VAS, BDI-2, HAM-D, HAM-A, YBOCS TSSL, MRVRSSignificant ↓ in MRVRS (primary outcome measure) in bilateral on stateSignificant improvement in tic counts and YGTSS and TSLS scores (secondary outcome measures)Quality of life indices improved (SF-36 and VAS scores)   
  [@b127-ndt-4-1111]   Case report                                        1    OCD, ADHD, Depression, anxiety                                               GPi bilaterally                                                                                  Follow-up: 6 months                                                                                                                                                                                                                                                                              none reported
                                                                                                                                                                                                                                                             Evaluation: YGTSS, TSSR, MRVRS YBOCS, SF-36 v2, BRIEF84% ↓ total YGTSS scores88% ↓ TSSR scores21% ↓ MRVRS scores65% ↑ SF-36 v2 scores                                                                                                                                                            
  [@b128-ndt-4-1111]   Case series                                        18   OCD (9 patients) SIB (9 patients) Depression (3 patients) ADHD (1 patient)   Thalamus (Ce-Pf andVoi) bilaterally                                                              Follow-up: 3--18 months                                                                                                                                                                                                                                                                          none reported
                                                                                                                                                                                                                                                             Evaluation: YGTSS65% ↓ in YGTSS scores17 patients demonstrated significant improvement of tic severity3 patients required no further medical Therapy                                                                                                                                             

**Abbreviations:** ADHD, attention deficit hyperactivity disorder; AIC, anterior internal capsule; BAS, brief anxiety scale; BDI, beck depression inventory; BIS, baratt's impulsivity scale; BRIEF, behaviour rating inventory of executive function; Ce-Pf, centromedian-parafascicular complex of the thalamus; Cm, centromedian nucleus; GAF, global assessment of functioning scale; GPi, globus pallidus pars internus; HAM-A, hamilton rating scale for anxiety; HAM-D, hamilton rating scale for depression; MADRS, montgomery-asberg depression rating scale; MRVRS, modified rush video rating scale; OCD, obsessive-compulsive disorder; RVBTS, rush video-based tic rating scale; Spv, substantia periventricularis; SCL-90-R, symptom checklist-90-R; SF-36, short form 36; SIB, self-injurious behaviour; STAI, state-trait anxiety Inventory; TSSL, tourette syndrome symptom list; TSSR, tic symptom self-report; v2, version 2; VAS, visual analog scale; Voi, nucleus ventro-oralis internus; YBOCS, yale-brown obsessive-compulsive scale; YGTSS, yale global tic severity scale.
